Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
RESEARCH presented at ACR Convergence 2025 highlights a potential new role for GLP-1 receptor agonists, medications widely used for type 2 diabetes and obesity, in the treatment of rheumatoid arthritis (RA)
As a result, the key drivers of PD progression remain incompletely defined
Sustaining a healthy lifestyle with diet and exercise is crucial for maintaining the results long-term
Correspondingly, ZIP13 knocking down resulted in the inhibition of human valve interstitial cells in an in vitro calcification model
Beyond the Basics: Advanced Considerations for Researchers For most protocols, the steps outlined above are all you'll need
US$ 21.52
US$ 29.71
US$ 25.64
US$ 26.89
US$ 23.77
US$ 23.92
